Squadron Master Fund LP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-03 4:05 pm Purchase | 2026-02-24 | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Squadron Master Fund LP | 3,676,900 5.100% | 3,676,900 (New Position) | Filing |